Betz Stephen F. 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Aug 28, 2024
Insider Transaction Report
Form 4
Betz Stephen F.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-08-26$53.19/sh−3,000$159,570→ 69,611 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.